down arrow

Basilea Pharmaceutica AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH0011432447
CHF
53.60
-0.4 (-0.74%)

Dec 16

SWX

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
81.00
-10.00
-20.71
-58.61
-102.05
-92.96
Shareholder's Funds
81.00
-10.00
-20.71
-58.61
-102.05
-92.96
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
97.97
112.97
170.81
218.94
241.42
197.74
Secured Loans
97.97
112.97
170.81
218.94
241.42
197.74
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-17.33
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
35.3
40.25
35.35
36.92
42.01
41.19
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
10.21
15.15
8.34
24.99
27.80
24.00
Total Non-Current Liabilities
131.21
135.70
166.71
131.47
281.68
238.93
Current Liabilities
Trade Payables
11.49
5.85
0.19
10.62
13.15
6.76
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
10.21
15.15
8.34
24.99
27.80
24.00
Total Current Liabilities
45.56
47.59
74.85
174.41
50.16
75.49
Total Liabilities
257.76
173.29
220.85
247.27
229.79
221.47
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
30.37
31.50
32.09
17.50
29.35
44.20
Less: Accumulated Depreciation
11.39
10.94
10.52
14.58
24.07
39.04
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
18.98
20.55
21.57
2.92
5.28
5.16
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
23.27
2.39
0.00
30.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.17
0.04
0.07
0.26
0.32
1.07
Total Non-Current Assets
36.85
21.14
45.48
6.20
6.27
36.61
Current Assets Loans & Advances
Current Investments
106.71
51.83
50.00
95.00
111.67
76.52
Inventories
31.61
26.41
24.24
22.78
21.19
18.57
Sundry Debtors
8.88
27.89
33.15
24.95
8.71
6.24
Cash and Bank
17.85
12.49
36.57
54.95
55.61
54.52
Other Current Assets
214.35
148.88
172.51
237.18
220.86
177.91
Short Term Loans and Advances
49.31
30.26
28.55
39.50
23.68
22.05
Total Current Assets
220.91
152.15
175.36
241.07
223.53
184.86
Net Current Assets (Including Current Investments)
175.35
104.55
100.51
66.66
173.37
109.37
Total Current Assets Excluding Current Investments
220.91
152.15
175.36
241.07
223.53
184.86
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
257.76
173.29
220.85
247.27
229.79
221.47
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
97.97
112.97
170.81
218.94
241.42
197.74
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 0.48% vs -27.34% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -12.30% vs 13.86% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -7.64% vs -4.73% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is 45.19% vs -13.24% in Dec 2023

Compare Balance Sheet Results of Basilea Pharmaceutica AG
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(CHF)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
81.00
467.64
-386.64
-82.68%
Shareholder's Funds
81.00
467.64
-386.64
-82.68%
Minority Interest
0
6.34
-6.34
-100.00%
Long-Term Borrowings
97.97
1.03
96.94
9,411.65%
Secured Loans
97.97
1.03
96.94
9,411.65%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
-17.33
67.66
-84.99
-125.61%
Other Long Term Liabilities
35.30
87.40
-52.10
-59.61%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
10.21
0.61
9.60
1,573.77%
Total Non-Current Liabilities
131.21
87.66
43.55
49.68%
Current Liabilities
Trade Payables
11.49
9.92
1.57
15.83%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
10.21
0.61
9.60
1,573.77%
Total Current Liabilities
45.56
45.30
0.26
0.57%
Total Liabilities
257.76
606.94
-349.18
-57.53%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
30.37
78.40
-48.03
-61.26%
Less: Accumulated Depreciation
11.39
51.10
-39.71
-77.71%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
18.98
27.30
-8.32
-30.48%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
29.88
-29.88
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0.17
8.39
-8.22
-97.97%
Total Non-Current Assets
36.85
417.14
-380.29
-91.17%
Current Assets Loans & Advances
Current Investments
106.71
92.59
14.12
15.25%
Inventories
31.61
12.68
18.93
149.29%
Sundry Debtors
8.88
17.77
-8.89
-50.03%
Cash and Bank
17.85
41.57
-23.72
-57.06%
Other Current Assets
214.35
167.01
47.34
28.35%
Short Term Loans and Advances
49.31
2.40
46.91
1,954.58%
Total Current Assets
220.91
189.80
31.11
16.39%
Net Current Assets (Including Current Investments)
175.35
144.51
30.84
21.34%
Total Current Assets Excluding Current Investments
220.91
189.80
31.11
16.39%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
257.76
606.94
-349.18
-57.53%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
97.97
1.03
96.94
9,411.65%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 95.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.48% vs -27.34% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 35.30 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -12.30% vs 13.86% in Dec 2023

Annual - Fixed Assets
Fixed Assets 18.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -7.64% vs -4.73% in Dec 2023

Annual - Investments
Investments 0.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 0.00% vs -100.00% in Dec 2023

Annual - Current Assets
Current Assets 220.91 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 45.19% vs -13.24% in Dec 2023

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."